Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Alan Goldberg currently holds 4,570 shares of Blueprint Medicines Corp (BPMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Alan Goldberg has been a net seller of BPMC stock. They have purchased $624.0K and sold $8.5M worth of shares.
Mark Alan Goldberg's most recent insider trade was on Jun 12, 2024, when they sold 4,570 shares at $0.00 per share.
Mark Alan Goldberg serves as Executive at Blueprint Medicines Corp (BPMC). They have executed 90 insider transactions totaling $9.1M over their tenure at the company.
Mark Alan Goldberg holds the position of Executive at Blueprint Medicines Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Mark Alan Goldberg has shown a selling trading pattern, with $624.0K in total purchases and $8.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Alan Goldberg was on Dec 24, 2020, when they sold $681.9K worth of BPMC shares. This transaction involved 5,455 shares at $125.00 per share.
Mark Alan Goldberg currently owns 4,570 shares of Blueprint Medicines Corp (BPMC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Alan Goldberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Alan Goldberg has 90 Form 4 filings on record as an insider at Blueprint Medicines Corp.
Set alerts for Mark Alan Goldberg and 40,000+ other insiders.